IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 320 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,205,312 | +12.4% | 48,618 | +1.6% | 0.02% | +17.6% |
| Q2 2023 | $1,962,494 | +13.3% | 47,830 | -1.3% | 0.02% | 0.0% |
| Q1 2023 | $1,732,227 | +89792.4% | 48,467 | -5.0% | 0.02% | – |
| Q4 2022 | $1,927 | -100.0% | 51,008 | -53.6% | 0.00% | -100.0% |
| Q3 2022 | $4,860,000 | -4.7% | 109,872 | -20.3% | 0.06% | +24.4% |
| Q2 2022 | $5,101,000 | -12.3% | 137,782 | -12.2% | 0.04% | 0.0% |
| Q1 2022 | $5,814,000 | +65.1% | 156,968 | +35.6% | 0.04% | +73.1% |
| Q4 2021 | $3,522,000 | +138.0% | 115,742 | +162.4% | 0.03% | +188.9% |
| Q3 2021 | $1,480,000 | +58.3% | 44,105 | +88.2% | 0.01% | +12.5% |
| Q2 2021 | $935,000 | +15.3% | 23,441 | +29.9% | 0.01% | 0.0% |
| Q1 2021 | $811,000 | -3.0% | 18,042 | +22.1% | 0.01% | -11.1% |
| Q4 2020 | $836,000 | +985.7% | 14,781 | +1029.2% | 0.01% | +800.0% |
| Q2 2020 | $77,000 | -78.2% | 1,309 | -70.0% | 0.00% | -85.7% |
| Q1 2019 | $354,000 | +48.7% | 4,360 | -5.4% | 0.01% | +40.0% |
| Q3 2018 | $238,000 | +3.0% | 4,611 | +2.9% | 0.01% | -50.0% |
| Q4 2017 | $231,000 | -15.7% | 4,481 | -9.8% | 0.01% | +42.9% |
| Q3 2017 | $274,000 | +4.2% | 4,970 | -2.6% | 0.01% | 0.0% |
| Q2 2017 | $263,000 | +15.9% | 5,102 | +38.9% | 0.01% | -36.4% |
| Q4 2015 | $227,000 | – | 3,673 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |